Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Post by
Inthepez
on Oct 07, 2022 12:09pm
NGL loving buying at these prices
before news hits next week. Definitely better than buying at 62 ;) . It will great by EOY lol!
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Oct 07, 2022 11:39am
RE:Ate @59 cents
mugoo needs to post another cut and paste from googling hydrofen sulfide
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 07, 2022 11:02am
Ate @59 cents
only 3 cents off of the 52 week low. no one buying including management and the longs who are trying to pump it.
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Oct 07, 2022 12:31am
Why buy now
why buy now, after financials it will probably be 10% cheaper. They are only spending money at this juncture
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 06, 2022 3:53pm
5 weeks until financials, 4 months P2 results
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Oct 05, 2022 3:58pm
RE:News after thanksgiving
Yes Sir Magic - looking forward to it !!! Always seems to be a moving target - but - we'll get it eventually. Lots still to be updated in 2022. What they owe: 1. commercial study
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 05, 2022 2:39pm
Q2 financials mid november
thats when we officialy will find out that P2 did in fact start at the end of september. i am not expecting any news before then.
(3)
•••
themagicbox
X
View Profile
View Bullboard History
Post by
themagicbox
on Oct 05, 2022 10:03am
News after thanksgiving
IR indicated no delays for trial start and more in a NR after thanksgiving (canadian thanksgiving that is). Don't take my word for it, go verify yourself with a email or call to IR.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 04, 2022 9:47am
as far as i know
nobody has an anti-ageing supplement. if ate got there act together they could have something on the shelf before the end of the year lol, i know it would be a big seller, lots of gullable people out
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 04, 2022 9:38am
Prevagen (no fda approval needed)
Three million people are estimated to have purchased Prevagen since it was first launched by Quincy Bioscience, a Wisconsin-based manufacturer, in 2007. Sales reached $165 million by mid-2015, and the
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 03, 2022 10:44pm
10 largest supplement companies (ate wrong line of business)
https://companiesmarketcap.com/dietary-supplements/largest-companies-by-market-cap/
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 03, 2022 10:34pm
these guys
should get into the supplement business, they could have an anti covid and a anti ageing supplement bolth would likely be big sellers, fda approval not neccesary, rake in some much needed cash to
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Oct 03, 2022 9:42pm
RE:RE:Today's H2S ... Thought of the Day !
Yes Sir Bagger ! Let me put it this way ... what you see isn't necessarily what you get with H2S. Sure there are specific purposes for the active ingredients used (like Naproxen) but then you
...more
(218)
•••
baggerx99
X
View Profile
View Bullboard History
Comment by
baggerx99
on Oct 03, 2022 2:56pm
RE:Today's H2S ... Thought of the Day !
hey Mugs, do you have a layman's version?
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Oct 03, 2022 12:11am
Today's H2S ... Thought of the Day !
H2S protects against stress-induced cellular senescence by initiating antioxidant responses and inhibition of mitochondrial ROS production. Others demonstrated that H2S induced the S-sulfhydration of
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >